Publication | Open Access

A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome

RheumatologyAutoimmune DiseaseAllergyPotent Therapeutic ActivityImmunologyAutoimmune DacryoadenitisAutoimmunityAutoantibodiesImmunomodulationBiological TherapyInflammatory Rheumatic DiseaseImmunotherapyMedicineMouse ModelRheumatoid Arthritis